NEKTAR THERAPEUTICS — Director's Dealing 2013

Sep 23, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2013-09-19

Reporting Person: WANG SUSAN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-09-19	Stock Option	$13.80	A	40000	Acquired	2021-09-18	Common Stock (40000)	Direct

Footnotes

F1: This stock option vests in equal monthly installments over a 1 year period beginning on September 30, 2013 based on the Reporting Person's continuous service to the Issuer.